December 26, 2025 In this episode, Scott, Mark, and Ray Painter answer listener questions about the new 2026 prostate biopsy CPT codes. They clarify global periods, explain the differences between transrectal and transperineal approaches, and tackle the nuances of coding for MRI-guided procedures—especially when using systems like Promaxo. They also break down the use of 55715 for additional targeted lesions, when modifiers like 52 may apply, and how payers might interpret these new c...
All content for Urology Coding and Reimbursement Podcast is the property of Mark Painter, Scott Painter and Dr. Ray Painter and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
December 26, 2025 In this episode, Scott, Mark, and Ray Painter answer listener questions about the new 2026 prostate biopsy CPT codes. They clarify global periods, explain the differences between transrectal and transperineal approaches, and tackle the nuances of coding for MRI-guided procedures—especially when using systems like Promaxo. They also break down the use of 55715 for additional targeted lesions, when modifiers like 52 may apply, and how payers might interpret these new c...
UCR 251: Initial Reactions to the 2026 Proposed CMS Rules
Urology Coding and Reimbursement Podcast
30 minutes
5 months ago
UCR 251: Initial Reactions to the 2026 Proposed CMS Rules
July 18, 2025 In this episode, Scott, Mark, and Ray Painter break down their first impressions of the 2026 proposed Medicare physician fee schedule. From conversion factor changes and telehealth updates to significant RVU and facility payment shifts, they explore what’s in store for urology and what it all means for your bottom line. PRS Coding and Reimbursement Hub Access the Hub Free Kidney Stone Coding Calculator Download Now PRS Coding Courses For Urologist For APPs For ...
Urology Coding and Reimbursement Podcast
December 26, 2025 In this episode, Scott, Mark, and Ray Painter answer listener questions about the new 2026 prostate biopsy CPT codes. They clarify global periods, explain the differences between transrectal and transperineal approaches, and tackle the nuances of coding for MRI-guided procedures—especially when using systems like Promaxo. They also break down the use of 55715 for additional targeted lesions, when modifiers like 52 may apply, and how payers might interpret these new c...
